Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing

Molecular Therapy

Volumn 20, Issue 12, 2012, Pages 2304-2314

  Lange, Margaret J ^a   Sharma, Tarun K ^b   Whatley, Angela S ^a   Landon, Linda A ^c   Tempesta, Michael A ^d   Johnson, Marc C ^a   Burke, Donald H ^a  

^a University of Missouri   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^c Research Communique   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; RIBOZYME; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; HUMAN IMMUNODEFICIENCY VIRUS; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; RNA CLEAVAGE; RNA PROCESSING; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84870619242     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.158     Document Type: Article

References (45)

1. Burke, DH, Scates, L, Andrews, K and Gold, L (1996). Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. J Mol Biol 264: 650-666.
2. Tuerk, C, MacDougal, S and Gold, L (1992). RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 89: 6988-6992.
3. Gopinath, SC (2007). Antiviral aptamers. Arch Virol 152: 2137-2157.
4. Held, DM, Kissel, JD, Patterson, JT, Nickens, DG and Burke, DH (2006). HIV-1 inactivation by nucleic acid aptamers. Front Biosci 11: 89-112.
5. Burnett, JC and Rossi, JJ. (2012). RNA-based therapeutics: current progress and future prospects. Chemistry & Biology 19, 60-71.
6. Joshi, PJ, North, TW and Prasad, VR (2005). Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol Ther 11: 677-686.
7. Neff, CP, Zhou, J, Remling, L, Kuruvilla, J, Zhang, J, Li, H et al. (2011). An aptamersiRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice. Sci Transl Med 3: 66ra6.
8. Chaloin, L, Lehmann, MJ, Sczakiel, G and Restle, T (2002). Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.Nucleic Acids Res 30: 4001-4008.
9. .Kolb, G, Reigadas, S, Castanotto, D, Faure, A, Ventura, M, Rossi, JJ et al. (2006). Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol 3: 150-156.
10. .Joshi, P and Prasad, VR (2002). Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). J Virol 76: 6545-6557.
11. .Ramalingam, D, Duclair, S, Datta, SA, Ellington, A, Rein, A and Prasad, VR (2011). RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. J Virol 85: 305-314.
12. .Zhang, W, Ke, W, Wu, SS Gan, L, Zhou, R Sun, CY et al. An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo. Peptides 30, 1816-1821 (2009).
13. Feng, H, Beck, J, Nassal, M and Hu, KH. A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication. PLoS One 6, e27862 (2011).
14. .Kaiser, N, Lischka, P, Wagenknecht, N and Stamminger, T (2009). Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84. J Virol 83: 11902-11913.
15. Umehara, T, Fukuda, K, Nishikawa, F, Sekiya, S, Kohara, M, Hasegawa, T et al. (2004). Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3. Nucleic Acids Symp Ser (Oxf) : 195-196.
16. .Romero-Lopez, C, Diaz-Gonzalez, R, Barroso-delJesus, A and Berzal-Herranz, A (2009). Inhibition of hepatitis C virus replication and internal ribosome entry site-dependent translation by an RNA molecule. J Gen Virol 90(Pt 7): 1659-1669.
17. .Tomai, E, Butz, K, Lohrey, C, von Weizsacker, F, Zentgraf, H and Hoppe-Seyler, F (2006). Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes. J Biol Chem 281: 21345-21352.
18. .Cheng, C, Dong, J, Yao, L, Chen, A, Jia, R, Huan, L et al. (2008). Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem Biophys Res Commun 366: 670-674.
19. .Syed, MA and Pervaiz, S (2010). Advances in aptamers. Oligonucleotides 20: 215-224.
20. .Joshi, PJ, Fisher, TS and Prasad, VR (2003). Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals. Curr Drug Targets Infect Disord 3: 383-400.
21. .Fichou, Y and Ferec, C (2006). The potential of oligonucleotides for therapeutic applications. Trends Biotechnol 24: 563-570.
22. .Li, N, Wang, Y, Pothukuchy, A, Syrett, A, Husain, N, Gopalakrisha, S et al. (2008). Aptamers that recognize drug-resistant HIV-1 reverse transcriptase. Nucleic Acids Res 36: 6739-6751.
23. .Ditzler, MA, Bose, D, Shkriabai, N, Marchand, B, Sarafianos, SG, Kvaratskhelia, M et al. (2011). Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates. Nucleic Acids Res 39: 8237-8247.
24. .Held, DM, Kissel, JD, Thacker, SJ, Michalowski, D, Saran, D, Ji, J et al. (2007). Crossclade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers. J Virol 81: 5375-5384.
25. .Held, DM, Kissel, JD, Saran, D, Michalowski, D and Burke, DH (2006). Differential susceptibility of HIV-1 reverse transcriptase to inhibition by RNA aptamers in enzymatic reactions monitoring specific steps during genome replication. J Biol Chem 281: 25712-25722.
26. Kissel, JD, Held, DM, Hardy, RW and Burke, DH (2007). Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs. AIDS Res Hum Retroviruses 23: 699-708.
27. Braun, SE, Shi, X, Qiu, G, Wong, FE, Joshi, PJ, Prasad, VR et al. (2007). Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoter. AIDS Res Ther 4: 24.
28. Benedict, CM, Pan, W, Loy, SE and Clawson, GA (1998). Triple ribozyme-mediated down-regulation of the retinoblastoma gene. Carcinogenesis 19: 1223-1230.
29. Heller, T, Saito, S, Auerbach, J, Williams, T, Moreen, TR, Jazwinski, A et al. (2005). An in vitro model of hepatitis C virion production. Proc Natl Acad Sci USA 102: 2579-2583.
30. Bussiere, F, Ledu, S, Girard, M, Heroux, M, Perreault, JP and Matton, DP (2003). Development of an efficient cis-trans-cis ribozyme cassette to inactivate plant genes. Plant Biotechnol J 1: 423-435.
31. Khvorova, A, Lescoute, A, Westhof, E and Jayasena, SD (2003). Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity. Nat Struct Biol 10: 708-712.
32. Burke, DH and Greathouse, ST (2005). Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities. BMC Biochem 6: 14.
33. De la Pena, M, Gago, S and Flores, R. (2003). Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity. EMBO J 22: 5561-5570.
34. Andang, M, Maijgren-Steffensson, C, Hinkula, J and Ahrlund-Richter, L (2004). Ciscleavage affects hammerhead and hairpin ribozyme steady-state levels differently and has strong impact on trans-targeting efficiency. Oligonucleotides 14: 11-21.
35. Saksmerprome, V, Roychowdhury-Saha, M, Jayasena, S, Khvorova, A and Burke, DH (2004). Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures. RNA 10: 1916-1924.
36. Muriaux, D and Rein, A (2003). Encapsidation and transduction of cellular genes by retroviruses. Front Biosci 8: d135-d142.
37. Martell, RE, Nevins, JR and Sullenger, BA (2002). Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol Ther 6: 30-34.
38. Thompson, JD, Ayers, DF, Malmstrom, TA, McKenzie, TL, Ganousis, L, Chowrira, BM et al. (1995). Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. Nucleic Acids Res 23: 2259-2268.
39. Stewart, M (2010). Nuclear export of mRNA. Trends Biochem Sci 35: 609-617.
40. Cullen, BR (2000). Nuclear RNA export pathways. Mol Cell Biol 20: 4181-4187.
41. Reed, SE, Staley, EM, Mayginnes, JP, Pintel, DJ and Tullis, GE (2006). Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J Virol Methods 138: 85-98.
42. Donald, C, Rio, GJH, Manuel Ares Jr. and Nilsen, TW. RNA: A Laboratory Manual. (John Inglis, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2011).
43. Pfaffl, MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
44. Zenklusen, D and Singer, RH (2010). Analyzing mRNA expression using single mRNA resolution fluorescent in situ hybridization. Meth Enzymol 470: 641-659.
45. Paul, CP, Good, PD, Li, SX, Kleihauer, A, Rossi, JJ and Engelke, DR (2003). Localized expression of small RNA inhibitors in human cells. Mol Ther 7: 237-247.